arrow
M

Ming-Huei Chen

Framingham Heart Study
H指数:61
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genetic study of von Willebrand factor antigen levels ≤ 50 IU/dL identifies variants associated with increased risk of von Willebrand disease and bleeding

von Willebrand因子抗原水平≤50 IU/dL的遗传学研究确定了与血管性血友病和出血风险增加相关的变异。

2025-05-120
PRE
Genome-wide meta-analysis of heavy menstrual bleeding reveals 36 risk loci

大范围月经量过多全基因组荟萃分析揭示了36个风险位点

Blood
IF23.1
2025-04-250
PRE
DNA methylation analysis is used to identify novel genetic loci associated with circulating fibrinogen levels in blood
2023-05-019
OAAI
Whole Genome Analysis of Venous Thromboembolism: the Trans-Omics for Precision Medicine Program

静脉血栓栓塞的全基因组分析: 精准医学的跨组学计划

2023-04-016
OA
Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors

静脉血栓栓塞基因组预测因子的跨血统研究

2022-10-1835
OA
Whole-exome sequencing of 14 389 individuals from the ESP and CHARGE consortia identifies novel rare variation associated with hemostatic factors
2022-05-127
OA
Elucidating mechanisms of genetic cross-disease associations at the PROCR vascular disease locus (vol 13, 1222, 2022)

阐明原血管疾病位点遗传交叉疾病关联的机制 (第13卷,1222,2022)

2022-04-060
OAAI
Whole-genome sequencing in diverse subjects identifies genetic correlates of leukocyte traits: The NHLBI TOPMed program

不同受试者的全基因组测序确定白细胞性状的遗传相关性: NHLBI TOPMed计划

2021-10-0118
OAAI
Multi-ethnic genome-wide association analyses of white blood cell and platelet traits in the Population Architecture using Genomics and Epidemiology (PAGE) Study (vol 22, 432, 2021)
2021-09-130
OAAI
Whole genome sequence analysis of platelet traits in the NHLBI Trans-Omics for Precision Medicine (TOPMed) initiative

NHLBI精准医学跨组学 (TOPMed) 计划中血小板性状的全基因组序列分析

2021-09-0614
OA
FGL1 as a modulator of plasma D-dimer levels: Exome-wide marker analysis of plasma tPA, PAI-1, and D-dimer
2021-08-013
OAAI
Genome sequencing unveils a regulatory landscape of platelet reactivity
2021-06-1533
OAAI